Non-surgical treatment of peri-implant disease is needed to remove microbial biofilm from the implant and/or abutment surface, reducing inflammation and preventing implant failure. This procedure is particularly useful for patients with peri-implant mucositis or early-stage peri-implantitis. For example, a patient with red, swollen gums around an implant may require non-surgical debridement to prevent progression to advanced peri-implantitis.
The primary benefit of non-surgical treatment of peri-implant disease is its ability to reduce inflammation and prevent implant failure by removing microbial biofilm. By addressing early-stage peri-implantitis, clinicians can preserve the implant and surrounding tissues, avoiding more invasive surgical procedures. Additionally, localized application of medicaments can enhance the effectiveness of the treatment, promoting healing and long-term stability. This approach is minimally invasive and cost-effective, making it an ideal first-line intervention for peri-implant disease.
For oral and maxillofacial surgeons, non-surgical treatment of peri-implant disease is essential for managing early-stage peri-implantitis and preventing implant failure. Surgeons should ensure that the procedure is performed accurately, using specialized instrumentation to remove biofilm effectively. This treatment also provides an opportunity to monitor the patient’s response and recommend surgical intervention if necessary. By incorporating non-surgical treatment into the care plan, surgeons can help ensure better outcomes for the patient.
